Brief: Redcare Pharmacy Q3 Adj. EBITDA Margin at 2%
05/11/2024 05:49
Nov 5 (Reuters) - Redcare Pharmacy Q3 adjusted EBITDA margin 2%
Recent news on Redcare Pharmacy NV
See all newsNetherlands' Redcare Pharmacy slightly beats Q3 revenue estimates on strong prescription sales in Germany
Brief: Redcare Pharmacy Q3 Sales EUR 847 Million
Brief: Redcare Pharmacy Appoints Peter Schmid Von Linstow As CEO
Europe Research Roundup: DEUTZ, Legrand, VAT
Brief: Redcare Pharmacy Now Expects FY Total Revenue Growth of 16% to 18%